Expert perspectives on the use of safinamide for Parkinson's disease in Portugal: insights from a Portuguese Delphi Consensus.

Rodrigues AM, Costa C, Gago M, Grunho M, Guedes LC, Morgadinho A, Rosas MJ, Simões R, Velon AG

Open source

DOI
10.57264/cer-2024-0228
Published
2025 Jul
Container
Journal of comparative effectiveness research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.57264/cer-2024-0228,
  title = {Expert perspectives on the use of safinamide for Parkinson's disease in Portugal: insights from a Portuguese Delphi Consensus.},
  author = {Rodrigues AM and Costa C and Gago M and Grunho M and Guedes LC and Morgadinho A and Rosas MJ and Simões R and Velon AG},
  year = {2025},
  journal = {Journal of comparative effectiveness research},
  doi = {10.57264/cer-2024-0228},
  url = {https://doi.org/10.57264/cer-2024-0228}
}

RIS

TY  - JOUR
TI  - Expert perspectives on the use of safinamide for Parkinson's disease in Portugal: insights from a Portuguese Delphi Consensus.
AU  - Rodrigues AM
AU  - Costa C
AU  - Gago M
AU  - Grunho M
AU  - Guedes LC
AU  - Morgadinho A
AU  - Rosas MJ
AU  - Simões R
AU  - Velon AG
PY  - 2025
JO  - Journal of comparative effectiveness research
DO  - 10.57264/cer-2024-0228
UR  - https://doi.org/10.57264/cer-2024-0228
ER  - 

APA

AM, R., C, C., M, G., M, G., LC, G., A, M., MJ, R., R, S., & AG, V. (2025). Expert perspectives on the use of safinamide for Parkinson's disease in Portugal: insights from a Portuguese Delphi Consensus.. Journal of comparative effectiveness research. https://doi.org/10.57264/cer-2024-0228

Source records